DCs prime tumor-specific CD4+ and CD8+ T cells by presenting three signals necessary for complete T cell activation: (1) peptide-MHC class I/II complexes; (2) costimulatory molecules CD80/CD86; and (3) cytokines that induce T cell proliferation and differentiation[8]. This evidence concerns the gene CD8A and neoplasm.